glyburide
Selected indexed studies
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. (J Cell Biol, 2009) [PMID:19805629]
- Glyburide and retinoic acid synergize to promote wound healing by anti-inflammation and RIP140 degradation. (Sci Rep, 2018) [PMID:29339732]
- Glibenclamide as a neuroprotective antidementia drug. (Arch Physiol Biochem, 2022) [PMID:32654523]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. (2009) pubmed
- Glyburide and retinoic acid synergize to promote wound healing by anti-inflammation and RIP140 degradation. (2018) pubmed
- Glibenclamide as a neuroprotective antidementia drug. (2022) pubmed
- Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. (1994) pubmed
- Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM. (1996) pubmed
- Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. (2009) pubmed
- Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. (2014) pubmed
- Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population. (2012) pubmed
- Glibenclamide-induced cholestasis. (1991) pubmed
- Bioequivalence of two oral formulations of glyburide (glibenclamide). (2007) pubmed